Nilotinib Interactions
There are 805 drugs known to interact with nilotinib, along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 289 are major, 498 are moderate, and 18 are minor.
- View all 805 medications that may interact with nilotinib
- View nilotinib alcohol/food interactions (1)
- View nilotinib disease interactions (8)
Most frequently checked interactions
View interaction reports for nilotinib and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Blincyto (blinatumomab)
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Ferrocite (ferrous fumarate)
- Flonase (fluticasone nasal)
- Hiprex (methenamine)
- Iron Sulfate (ferrous sulfate)
- Jardiance (empagliflozin)
- Kyprolis (carfilzomib)
- Lasix (furosemide)
- Levothyrox (levothyroxine)
- Lexapro (escitalopram)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Panadol Osteo (acetaminophen)
- Paracetamol (acetaminophen)
- Plaquenil (hydroxychloroquine)
- Protonix (pantoprazole)
- Prozac (fluoxetine)
- Retinol (vitamin a topical)
- Revlimid (lenalidomide)
- Rifadin (rifampin)
- Sprycel (dasatinib)
- Symbicort (budesonide / formoterol)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
Nilotinib alcohol/food interactions
There is 1 alcohol/food interaction with nilotinib.
Nilotinib disease interactions
There are 8 disease interactions with nilotinib which include:
- pancreatitis
- QT prolongation
- cardiovascular disease
- fluid retention
- bone marrow suppression
- electrolyte abnormalities
- hepatic impairment
- lactose intolerance
Report options
More about nilotinib
- nilotinib consumer information
- Compare alternatives
- Reviews (40)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Tasigna
Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia ...
Scemblix
Scemblix (asciminib) is an oral kinase inhibitor that may be used to treat adults with a type of ...
Bosulif
Bosulif is a kinase inhibitor that may be used to treat adults and some children aged 1 year and ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.